**Patient Discharge Summary**

**Patient Information:**
- **Patient Name:** John Doe
- **Age:** 58
- **Gender:** Male
- **Hospital ID:** 123456789
- **Admission Date:** October 1, 2023
- **Discharge Date:** October 7, 2023
- **Admitting Physician:** Dr. Jane Smith, MD, Cardiovascular Unit

**Chief Complaint:**
The patient presented with persistent headaches and episodes of dizziness over the past month.

**History of Present Illness:**
Mr. John Doe, a 58-year-old male with a past medical history significant for obesity and type 2 diabetes mellitus, was admitted to the cardiovascular unit on October 1, 2023, with complaints of severe headaches and occasional dizziness. He reported these symptoms had been progressively worsening over the last month. He also noted increased fatigue and episodes of blurred vision. Mr. Doe has a family history of cardiovascular disease and hypertension.

**Physical Examination Findings:**
- **Blood Pressure:** 160/100 mm Hg in the right arm, 158/98 mm Hg in the left arm
- **Heart Rate:** 78 bpm
- **Height:** 175 cm
- **Weight:** 102 kg
- **BMI:** 33.3 kg/m^2
- **Waist Circumference:** 108 cm

**Diagnostic Workup:**
- **Urinalysis:** Normal
- **Lipid Panel:** Elevated LDL cholesterol
- **Metabolic Panel:** Normal glucose levels, considering the patient is on medication for type 2 diabetes
- **Fasting Plasma Glucose:** Slightly elevated
- **ECG:** Normal sinus rhythm with no evidence of hypertrophy or ischemia
- **Thyroid-Stimulating Hormone Levels:** Within normal limits

**Hospital Course:**
Mr. Doe was diagnosed with arterial hypertension based on repeated blood pressure measurements showing an average of 160/100 mm Hg. His initial management included lifestyle counseling and initiation of pharmacotherapy. Given his history of diabetes and obesity, a comprehensive approach was taken to manage his hypertension and mitigate the risk of cardiovascular complications.

**Medication Management:**
- **Lisinopril (an ACE inhibitor):** Started at 10 mg once daily, adjusted to 20 mg once daily after 2 days due to persistent high blood pressure readings.
- **Amlodipine (a dihydropyridine calcium channel blocker):** 5 mg once daily, initiated on the third day of hospitalization to achieve better blood pressure control.

**Lifestyle Modifications:**
Mr. Doe received counseling on significant lifestyle modifications, including dietary changes to reduce sodium intake to less than 1500 mg/day, encouragement of weight loss to achieve a BMI within the normal range, and initiation of a regular physical activity program tailored to his capacity and preferences. He was also educated on the importance of smoking cessation, although he is not a smoker.

**Follow-up and Patient Education:**
Mr. Doe was educated on the importance of adherence to his medication regimen and lifestyle modifications. He was instructed on how to monitor his blood pressure at home and advised to record his readings for review during follow-up visits. A follow-up appointment was scheduled with Dr. Jane Smith in 2 weeks to reassess blood pressure control and adjust the treatment regimen as necessary. Mr. Doe was also referred to a dietitian for further counseling on a heart-healthy diet and to a diabetes educator to optimize his glycemic control.

**Discharge Medications:**
- Lisinopril 20 mg orally once daily
- Amlodipine 5 mg orally once daily

**Recommendations:**
- Adhere to prescribed medication regimen.
- Follow a low-sodium, heart-healthy diet.
- Engage in regular physical activity.
- Monitor blood pressure at home twice daily.
- Schedule and attend all follow-up appointments.

**Discharge Instructions:**
Mr. Doe was advised to seek immediate medical attention if he experiences symptoms such as chest pain, shortness of breath, severe headaches, or any signs of a hypertensive crisis. He was also provided with a blood pressure log to record his daily readings.

**Physician's Signature:**
Dr. Jane Smith, MD
Cardiovascular Unit